Platform Session A (non-accredited)
19 Mar 2025
Venue:
Los Angeles Convention Centre
Meeting Room:
West Exhibit Hall B
Cancer Genetics and Therapeutics
,
Clinical Genetics and Therapeutics
-
Accredited:
- Not Accredited
Platform presentations are abstract submissions chosen by the abstract review committee to orally present their research. It is a 13-minute presentation followed by a 2-minute Q&A.
O04 - Longitudinal Validation in UK Biobank of a Breast Cancer Risk Model Combining a Multiple-Ancestry Polygenic Score with Traditional Risk Factors
O20 - Improved Clinical Management Following Diagnosis with Familial Hypercholesterolemia in the Helix Research Network Population Genomics Screening Program
O14 - Administration of Eladocagene Exuparvovec Using the SmartFlow Magnetic Resonance-Compatible Ventricular Cannula in Pediatric Patients with Aromatic L-Amino Acid Decarboxylase Deficiency
O05 - Implementation of Pan-Cancer Universal Germline Testing as Standard of Care in an Ethnically Diverse, Rural, Underserved Community Oncology Practice
O04 - Longitudinal Validation in UK Biobank of a Breast Cancer Risk Model Combining a Multiple-Ancestry Polygenic Score with Traditional Risk Factors
O20 - Improved Clinical Management Following Diagnosis with Familial Hypercholesterolemia in the Helix Research Network Population Genomics Screening Program
O14 - Administration of Eladocagene Exuparvovec Using the SmartFlow Magnetic Resonance-Compatible Ventricular Cannula in Pediatric Patients with Aromatic L-Amino Acid Decarboxylase Deficiency
O05 - Implementation of Pan-Cancer Universal Germline Testing as Standard of Care in an Ethnically Diverse, Rural, Underserved Community Oncology Practice
Agenda
-
-
Longitudinal Validation in UK Biobank of a Breast Cancer Risk Model Combining a Multiple-Ancestry Polygenic Score with Traditional Risk Factors12:15 PM – 12:30 PM -
Improved Clinical Management Following Diagnosis with Familial Hypercholesterolemia in the Helix Research Network Population Genomics Screening Program12:30 PM – 12:45 PM -
Administration of Eladocagene Exuparvovec Using the SmartFlow Magnetic Resonance-Compatible Ventricular Cannula in Pediatric Patients with Aromatic ʟ-Amino Acid Decarboxylase Deficiency
12:45 PM – 1:00 PM -
Implementation of Pan-Cancer Universal Germline Testing as Standard of Care in an Ethnically Diverse, Rural, Underserved Community Oncology Practice1:00 PM – 1:15 PM -
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}